Shionogi & Co., Ltd. (OTCMKTS:SGIOF – Get Free Report) shares traded down 0.2% during mid-day trading on Thursday . The company traded as low as $12.87 and last traded at $12.87. 121 shares were traded during trading, a decline of 96% from the average session volume of 2,743 shares. The stock had previously closed at $12.90.
Shionogi & Co., Ltd. Price Performance
The business’s fifty day moving average price is $26.64 and its 200 day moving average price is $37.69.
About Shionogi & Co., Ltd.
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Further Reading
- Five stocks we like better than Shionogi & Co., Ltd.
- Short Selling: How to Short a Stock
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- The Significance of Brokerage Rankings in Stock Selection
- MarketBeat Week in Review – 11/4 – 11/8
- Health Care Stocks Explained: Why You Might Want to Invest
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Shionogi & Co. Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.
